文献速递前列腺癌

前列腺癌根治性切除术中不同范围淋巴结清扫的获益与危害:一项系统综述

The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
PubMed 文献 · Eur Urol · 2017-01-24

该系统综述纳入66项研究、共275269例患者,评估前列腺癌根治性切除术中盆腔淋巴结清扫(PLND)不同范围对肿瘤学和非肿瘤学结局的获益与危害。多数研究显示PLND范围越大,手术时间、出血量、住院时间和术后并发症等不良结局越明显,而生存方面各组无显著差异;当前证据质量差,需稳健且把握度充足的临床试验。

要点

  • PLND范围越大,手术时间、出血量、住院时间和术后并发症等不良结局越明显。
  • 生存方面各组无显著差异,生化复发和临床复发比较结果相互矛盾。
  • 尿控和勃起功能恢复方面无显著差异。

核心结论

  • PLND及其扩大范围与更差的术中和围手术期结局相关,而当前文献仍未显示直接的治疗获益。
  • 当前证据质量差,表明需要稳健且把握度充足的临床试验。

研究设计与样本

  • 系统综述,检索MEDLINE、MEDLINE In-Process、Embase和Cochrane Central Register of Controlled Trials,截至2015年12月。
  • 纳入比较未行PLND、局限、标准和(超)扩大PLND并报告肿瘤学和非肿瘤学结局的比较性研究。
  • 共纳入66项研究,招募275269例患者(44篇全文和22篇会议摘要)。
  • 29项研究涉及肿瘤学结局,其中1项为随机临床试验(RCT);43项研究涉及非肿瘤学结局,其中3项为RCT。
  • 进行了偏倚风险和混杂评估,并采用叙述性综合。

主要发现

  • 大多数研究存在高偏倚风险和混杂。
  • 比较生化和临床复发时出现相互矛盾的结果,而生存方面各组无显著差异。
  • 大多数研究显示,PLND范围越大,手术时间、出血量、住院时间和术后并发症方面的不良结局越严重。
  • 尿控和勃起功能恢复方面无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 大多数研究存在高偏倚风险和混杂。
  • 当前证据质量差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is controversy regarding the therapeutic role of pelvic lymph node dissection (PLND) in patients undergoing radical prostatectomy for prostate cancer (PCa). OBJECTIVE: To systematically review the relevant literature assessing the relative benefits and harms of PLND for oncological and non-oncological outcomes in patients undergoing radical prostatectomy for PCa. EVIDENCE ACQUISITION: MEDLINE, MEDLINE In-Process, Embase, and the Cochrane Central Register of Controlled Trials were searched up to December 2015. Comparative studies evaluating no PLND, limited, standard, and (super)-extended PLND that reported oncological and non-oncological outcomes were included. Risk-of-bias and confounding assessments were performed. A narrative synthesis was undertaken. EVIDENCE SYNTHESIS: Overall, 66 studies recruiting a total of 275,269 patients were included (44 full-text articles and 22 conference abstracts). Oncological outcomes were addressed by 29 studies, one of which was a randomized clinical trial (RCT). Non-oncological outcomes were addressed by 43 studies, three of which were RCTs. There were high risks of bias and confounding in most studies. Conflicting results emerged when comparing biochemical and clinical recurrence, while no significant differences were observed among groups for survival. Conversely, the majority of studies showed that the more extensive the PLND, the greater the adverse outcomes in terms of operating time, blood loss, length of stay, and postoperative complications. No significant differences were observed in terms of urinary continence and erectile function recovery. CONCLUSIONS: Although representing the most accurate staging procedure, PLND and its extension are associated with worse intraoperative and perioperative outcomes, whereas a direct therapeutic effect is still not evident from the current literature. The current poor quality of evidence indicates the need for robust and adequately powered clinical trials. PATIENT SUMMARY: Based on a comprehensive review of the literature, this article summarizes the benefits and harms of removing lymph nodes during surgery to remove the prostate because of PCa. Although the quality of the data from the studies was poor, the review suggests that lymph node removal may not have any direct benefit on cancer outcomes and may instead result in more complications. Nevertheless, the procedure remains justified because it enables accurate assessment of cancer spread.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Fossati N, Willemse PM, Van den Broeck T, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. 2017. PMID: 28126351. doi:10.1016/j.eururo.2016.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。